Feasibility and Acceptability of a Novel Cervicovaginal Lavage Self-Sampling Device Among Women in Kigali, Rwanda

Ndayisaba, Gilles MD*; Verwijs, Marijn Christiaan BSc*†; van Eeckhoudt, Servaas MD*; Gasarabwe, Ammiel CO*; Hardy, Liselotte MSc; Borgdorff, Hanneke MD; Kestelyn, Evelyne MA*†; Jespers, Vicky A. MSc, MD; van de Wijgert, Janneke MSc, MPH, PhD*†§

Sexually Transmitted Diseases: July 2013 - Volume 40 - Issue 7 - p 552–555
doi: 10.1097/OLQ.0b013e31828e5aa5
Note

Abstract: The Delphi Screener is a novel cervicovaginal lavage self-sampling device. Sixty women in Kigali (Rwanda) assessed the Screener at 2 consecutive visits. Between the visits, ease of use improved, reported difficulties decreased, and the collected sample weight increased. Most women preferred self-collection over a speculum examination.

The Delphi Screener, a novel cervicovaginal lavage self-sampling device, was feasible and acceptable among women in Rwanda, particularly after some practice.

From the *Rinda Ubuzima, Kigali, Rwanda; †Amsterdam Institute for Global Health and Development, Amsterdam, the Netherlands; §Institute of Infection and Global Health, University of Liverpool, Liverpool, UK; and ‡Institute of Tropical Medicine, Antwerp, Belgium

Acknowledgments: The authors thank the volunteers who participated in this study, the Rinda Ubuzima staff, the Rinda Ubuzima Advisory Board, and Marloes Voll, René Hol, and Maarten Wiegerinck of Delphi Bioscience (Scherpenzeel, the Netherlands). The authors also thank Delphi Bioscience for their kind donation of Delphi Screeners. The data collection was funded by the European and Developing Countries Clinical Trials Partnership (EDCTP) as part of a grant titled “Characterisation of novel microbicide safety biomarkers in East and South Africa.” The views expressed in this manuscript are those of the authors and do not necessarily represent the views of EDCTP and Delphi Bioscience.

Sources of support: The data collection was funded by the European and Developing Countries 31 Clinical Trials Partnership (EDCTP) as part of a grant titled “Characterisation of novel microbicide safety biomarkers in East and South Africa.” Delph Screeners were donated by Delphi Bioscience 32 BV (Scherpenzeel, the Netherlands).

Statement of authorship: I hereby declare that all authors have sufficiently participated in the conception and design of this work or the analysis and interpretation of the data and in the writing and reviewing of the manuscript, to take public responsibility for it. All authors reviewed the final version and approved it for publication. This manuscript has not been submitted elsewhere.

Ethical adherence: The study was approved by the Rwanda National Ethics Committee and the Ethics Committee of Ghent University Hospital in Ghent, Belgium. All participants in the study provided written informed consent before enrolling in the study.

Correspondence: Marijn Christiaan Verwijs, BSc, Amsterdam Institute for Global Health and Development, Trinity Building C, Pietersbergweg 17, 1105 BM Amsterdam, the Netherlands. E-mail: m.c.verwijs@students.uu.nl.

Received for publication December 4, 2012, and accepted February 20, 2013.

© Copyright 2013 American Sexually Transmitted Diseases Association